Posts by Muana Minkoué
CSEM and ClexBio create a bioreactor to manufacture tissue-engineered cardiovascular implants
A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio, a Nordics-based startup specialised in regenerative medicine. Funded by the Research Council of Norway, their solution aims to improve the lives of millions of people suffering from severe chronic venous insufficiency (CVI) by…
Read MoreThe Biopôle Review – 2023 edition
Check out all the key figures from Biopôle’s community, inspiring interviews and more in their latest review. Biopôle, the life sciences campus based in Lausanne, brings together a strong community of industry and academia. It offers a world-class combination of infrastructure, added value services, living space and community engagement where partners can thrive…
Read MoreAtinary and Takeda collaborate to drive innovation in healthcare
Atinary Technologies, a Vaud based startup, announced a strategic collaboration with Takeda, Japanese largest pharmaceutical company. This partnership brings together the two company’s complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery. Through this collaboration, Takeda will leverage Atinary’s leading AI Self-Driving Labs technology,…
Read MoreInnovative materials to combat bacteria
A UNIGE team is developing new alloys with bactericidal properties to combat antibiotic-resistant germs. While crucial to biotechnology, bacteria can also cause severe disease, exacerbated by their increasing resistance to antibiotics. This duality between economic benefits and infectious risks underlines the importance of finding ways to control their development. A team at the…
Read MoreAlys Pharmaceuticals launches with $100 Million financing from Medicxi
Formed through the aggregation of six-asset centric Medicxi companies, including Aldena Therapeutics, Alys boasts a robust R&D pipeline of cutting-edge programmes and platforms targeting multiple dermatological indications. Co-founded by Medicxi and several world-leading dermatology and scientific experts, Alys is a Boston and Geneva-based cutting edge pure-play immuno-dermatology company. It combines the assets and…
Read MoreCHF 870 Million invested in Swiss medtech and biotech companies
In the midst of an unfavourable environment, the life sciences’ sector continues to attract investors in Switzerland according to the Swiss Venture Capital Report 2024. In 2023, the downturn on the global venture capital market reached Switzerland. Swiss startups received a total of CHF 2.6 Billion last year, 35% less than in 2022.…
Read MoreFONGIT Life Sciences Café+Croissant
The next FONGIT Café+Croissant is taking place on 22 January 2026 at Campus Biotech Geneva Come find out what’s been going on in the Geneva life sciences startup scene, hear from entrepreneurs themselves, and expand your professional network over coffee and croissants. 🗓 22 January 2026 | 9.30 AM – 10.30 AM📍Campus Biotech – Geneva➡️ Information &…
Read MoreHack Summit
Hack Summit is taking place on 22-23 April 2026 in Lausanne. This year’s programme celebrates Founders and Innovators relentlessly working to build, scale and deploy solutions for abundance. Surround yourself with 1,200 Startups, Investors and Operators all working towards a more sustainable and resilient future. Thematic Days will drill into : - Industrial Renaissance: Advanced Automation,New…
Read MoreFirst-in-Human implantation for Novostia’s heart valve
The Vaud-based startup, located at the Biopôle, successfully implanted its TRIFLO valve in a human. Novostia, a pioneering medical technology company, proudly announces a significant milestone in its mission to revolutionize cardiovascular care. Last December, the company has successfully implanted its groundbreaking TRIFLO Heart Valve in a human patient for the first time.…
Read MoreDebiopharm Innovation Fund invests in MedaSystems
MedaSystems secures additional funding from Debiopharm Innovation Fund to accelerate global access to pre-approval treatment. Medasystems, a pioneer in software to provide access to pre-approval medicine, announced funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling…
Read More